Article ID Journal Published Year Pages File Type
6046159 Preventive Medicine 2016 41 Pages PDF
Abstract
The evidence does not support CXR screening with or without sputum cytology for lung cancer. High quality evidence showed that in selected high-risk individuals, LDCT screening significantly reduced lung cancer mortality and all-cause mortality. However, for its implementation at a population level, the current evidence warrants the development of standardized practices for screening with LDCT and follow-up invasive testing to maximize accuracy and reduce potential associated harms.
Related Topics
Health Sciences Medicine and Dentistry Complementary and Alternative Medicine
Authors
, , , , , , ,